Department of Chemistry, Louisiana State University, 133 Choppin Hall, Baton Rouge, LA 70803, USA.
Molecules. 2024 Jan 4;29(1):279. doi: 10.3390/molecules29010279.
Monoterpenes and meroterpenes are two large classes of isoprene-based molecules produced by terrestrial plants and unicellular organisms as diverse secondary metabolites. The global rising incidence of cancer has led to a renewed interest in natural products. These monoterpenes and meroterpenes represent a novel source of molecular scaffolds that can serve as medicinal chemistry platforms for the development of potential preclinical leads. Furthermore, some of these natural products are either abundant, or their synthetic strategies are scalable as it will be indicated here, facilitating their derivatization to expand their scope in drug discovery. This review is a collection of representative updates (from 2016-2023) in biologically active monoterpene and meroterpenoid natural products and focuses on the recent findings of the pharmacological potential of these bioactive compounds as well as the newly developed synthetic strategies employed to access them. Particular emphasis will be placed on the anticancer and antioxidant potential of these compounds in order to raise knowledge for further investigations into the development of potential anti-cancer therapeutics. The mounting experimental evidence from various research groups across the globe regarding the use of these natural products at pre-clinical levels, renders them a fast-track research area worth of attention.
单萜类化合物和倍半萜类化合物是由陆地植物和单细胞生物产生的两种大型异戊二烯类分子,作为多样化的次生代谢产物。全球癌症发病率的上升促使人们重新关注天然产物。这些单萜类化合物和倍半萜类化合物代表了一类新型的分子支架来源,可以作为药物化学平台,用于开发有潜力的临床前先导化合物。此外,这些天然产物中的一些要么丰富,要么其合成策略具有可扩展性,正如这里所指出的,这有利于它们的衍生化,以扩大它们在药物发现中的应用范围。本文综述了 2016 年至 2023 年具有生物活性的单萜类化合物和倍半萜类天然产物的代表性更新,重点介绍了这些生物活性化合物的药理潜力的最新发现,以及为获得这些化合物而采用的新合成策略。特别强调了这些化合物的抗癌和抗氧化潜力,以提高对进一步开发潜在抗癌疗法的认识。全球各个研究小组在临床前水平上使用这些天然产物的实验证据不断增加,使它们成为一个值得关注的快速发展的研究领域。